Table of Content

1. Executive Summary


2. China Cancer Drugs Market


3. Market Share – China Anti-Cancer Drugs

3.1 By Drugs
3.2 By Cancer
3.3 By Therapy


4. Drugs – China Cancer Market

4.1 Cytotoxic Drugs

4.1.1 Antimetabolities
4.1.2 Plant Alkaloids
4.1.3 Alkylating Agents

4.2 Targeted Drugs
4.3 Monoclonal Antibiotics
4.4 Hormonal Drugs
4.5 Traditional Chinese Medicine (TCM)
4.6 Others


5. Cancer Type – Market

5.1 Lung Cancer
5.2 Stomach Cancer
5.3 Breast Cancer
5.4 Esophageal Cancer
5.5 Liver Cancer
5.6 Others


6. Therapy – China Cancer Market

6.1 Chemotherapy
6.2 Targeted Therapy
6.3 Hormonal Therapy
6.4 Others


7. Company Analysis

7.1 Merck

7.1.1 Company Overview
7.1.2 Financial Insights

7.2 Celgene

7.2.1 Company Overview
7.2.2 Financial Insights

7.3 Eli Lilly

7.3.1 Company Overview
7.3.2 Financial Insights

7.4 Roche

7.4.1 Company Overview
7.4.2 Financial Insights

7.5 Sino BioPharma

7.5.1 Company Overview
7.5.2 Financial Insights


8. Growth Drivers

8.1 Growing Awareness towards Cancer Diagnosis and Treatment
8.2 Increasing Use of Targeted Therapy
8.3 Increasing Research and Development Activities
8.4 Cutting Import Duties on Cancer Drugs


9. Challenges

9.1 High Cost of Cancer Drugs
9.2 Major Side Effects of Cancer Treatment



List of Figures



Figure 2?1: China – Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 2?2: China – Forecast for Anti-Cancer Drugs Market (Billion US$), 2018 – 2024

Figure 3?1: By Drugs – China Anti-Cancer Drugs Market Share (%), 2011 – 2017
Figure 3?2: By Drugs – Forecast for China Anti-Cancer Drugs Market Share (%), 2018 – 2024
Figure 3?3: By Cancer – China Anti-Cancer Drugs Market Share (%), 2011 – 2017
Figure 3?4: By Cancer – Forecast for China Anti-Cancer Drugs Market Share (%), 2018 – 2024
Figure 3?5: By Therapy – China Anti-Cancer Drugs Market Share (%), 2011 – 2017
Figure 3?6: By Therapy – Forecast for China Anti-Cancer Drugs Market Share (%), 2018 – 2024

Figure 4?1: Cytotoxic Drugs – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4?2: Cytotoxic Drugs – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4?3: Antimetaboloties – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4?4: Antimetaboloties – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4?5: Plant Alkaloids – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4?6: Plant Alkaloids – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4?7: Alkylating Agents – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4?8: Alkylating Agents – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4?9: Targeted Drugs – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4?10: Targeted Drugs – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4?11: Monoclonal Antibiotics – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4?12: Monoclonal Antibiotics – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4?13: Hormonal Drugs – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4?14: Hormonal Drugs – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4?15: Traditional Chinese Medicine (TCM) – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4?16: Traditional Chinese Medicine (TCM) – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4?17: Others – China Anti-Cancer Drugs Market (Million US$), 2011 – 2017
Figure 4?18: Others – Forecast for China Anti-Cancer Drugs Market (Million US$), 2018 – 2024

Figure 5?1: Lung Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 5?2: Lung Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 5?3: Stomach Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 5?4: Stomach Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 5?5: Breast Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 5?6: Breast Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 5?7: Esophageal Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 5?8: Esophageal Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 5?9: Liver Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 5?10: Liver Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 5?11: Others – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 5?12: Others – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024

Figure 6?1: Chemotherapy – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 6?2: Chemotherapy – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 6?3: Targeted Therapy – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 6?4: Targeted Therapy – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 6?5: Hormonal Therapy – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 6?6: Hormonal Therapy – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 6?7: Others – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 6?8: Others – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024

Figure 7?1: Merck – Global Oncology Product Sales (Million US$), 2011 – 2017
Figure 7?2: Merck – Forecast for Global Oncology Product Sales (Million US$), 2018 – 2024
Figure 7?3: Celgene – Global Net Product Sales (Million US$), 2011 – 2017
Figure 7?4: Celgene – Forecast for Global Net Product Sales (Million US$), 2018 – 2024
Figure 7?5: Eli Lilly – Global Oncology Revenue (Million US$), 2011 – 2017
Figure 7?6: Eli Lilly – Forecast for Global Oncology Revenue (Million US$), 2018 – 2024
Figure 7?7: Roche – Global Oncology Products Sales (Million US$), 2011 – 2017
Figure 7?8: Roche – Forecast for Global Oncology Products Sales (Million US$), 2018 – 2024
Figure 7?9: Sino BioPharma – Global Oncology Revenue (Million US$), 2012 – 2017
Figure 7?10: Sino BioPharma – Forecast for Global Oncology Revenue (Million US$), 2018 – 2024

 

List of Tables


N/A